Study Population

AG Alin L. Girnita
LW Lin Wang
AC Adriana I. Colovai
PA Patrick Ahearn
YA Yorg Azzi
MM Madhav C. Menon
MF Marcelo Fernandez-Vina
HG Howard M. Gebel
EW E. Steve Woodle
PC Paolo Cravedi
JM Jonathan S. Maltzman
EA Enver Akalin
ask Ask a question
Favorite

Our study included consecutive consenting adult kidney transplant recipients followed-up from April 2020 to February 2021 during hospitalization or at follow-up clinic visits at Mount Sinai and Montefiore Medical Center in New York with an ongoing or prior SARS-CoV-2 infection diagnosed through real-time polymerase chain reaction (RT-PCR) of nasopharyngeal swab samples as previously described.19 We recorded epidemiological, clinical, and laboratory data in an ad hoc database.

The study received appropriate approval from the ethics and scientific committees of the participating centers (institutional review board titles/numbers: STUDY-20-01922, Mount Sinai Medical Center; IRB-2020-11662 Montefiore Medical Center; IRB-56413 Stanford University). All patients provided informed consent.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A